Blood Stream Infection Testing Market Research Provides an In-Depth Analysis on the Future Growth Prospects and MGlobal Microbubble Contrast Media Market Trends Adopted by the Competitors
Blood
stream infections, which are caused by pathogens can
intervene with the normal defenses of the body and prevent immune
system from working properly. Blood stream infections testing help
the doctors to determine the specific bacteria or organism causing
blood infection. Human health is at risk due to increasing
population, which has led to rise in various infectious diseases.
According to the World Bank 2016 report, the global population
reached up to 7.44 billion. This has contributed to the growth of the
blood stream infection testing market. The demand for quicker results
and rapid diagnosis is increasing the demand for blood stream
infection testing globally. Moreover, rising incidence of hospital
acquired infectious diseases and lowered immunity levels due to high
pollution levels are also increasing the demand for blood stream
infection tests.
Blood
Stream Infection Testing Market - Regional Insights
On the basis
of region, the global blood stream infection testing market is
segmented into North America, Europe, Latin America, Asia Pacific,
Middle East, and Africa. North America accounted for the largest
market share in the global blood stream infection testing market,
owing to rising awareness among the people, high infection rates,
better medical facilities, and high adoption of the innovative
products. Moreover, government support towards the infection-free
states and society is also accelerating the growth of blood stream
infection testing market in this region. For instance, in 2018, the
U.S. Food and Drug Administration (FDA) authorized city-based blood
test to aid in the evaluation of concussion in adults.
Moreover,
Asia Pacific is expected to witness significant growth in the market
over the forecast period, owing to rising number of vulnerable
population to various chronic diseases and wide availability of
innovative products offering better solutions to the patients at
marginally lower costs. For instance, in 2017, a group of researchers
led by the National Cancer Center Japan (NCC), together with Toray
Industries, Inc. developed a new method that could detect thirteen
different cancer types with a single drop of blood.
Blood
Stream Infection Testing Market - Competitive Landscape
The key
players operating in the global blood stream infection testing market
include bioMérieux SA, Becton, Dickinson and Company, AB Sciex,
IRIDICA, Abbot Laboratories, Cepheid Inc, C. R. Bard, Inc., F.
Hoffmann-La Roche AG, Nanoshpere, Dade Behring, AdvanDX, Siemens
Healthcare, Alere Inc., Roche Diagnostics, Eurogentec, Cepheid,
Luminex Corporation, and Thermo Fisher Scientific.
Request For
Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1727
Blood
Stream Infection Testing Market Taxonomy
On the
basis of product type, the global blood stream infection testing
market is segmented into:
-
Instruments
-
Reagents
-
Others
On the
basis of technology, the global blood stream infection testing market
is segmented into:
-
Conventional Testing
-
Non-Conventional Testing
On the
basis of test type, the global blood stream infection testing market
is segmented into:
-
Conventional Blood Culture Tests
-
PCR Method
-
Nucleic Acid Testing
-
Mass Spectroscopy
-
Point-of-Care Testing
On the
basis of end user, the global blood stream infection testing market
is segmented into:
-
Hospitals
-
Independent Diagnostic Centers
-
Others
On the
basis of region, the global blood stream infection testing market is
segmented into:
-
North America
-
Latin America
-
Europe
-
Asia Pacific
-
Middle East
-
Africa
About
Coherent Market Insights
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us
Mr.
Shah
Coherent
Market Insights
1001
4th Ave, #3200
Seattle,
WA 98154
Tel:
+1-206-701-6702

Comments
Post a Comment